Literature DB >> 10601283

The hydrophilic isoform of glutamate decarboxylase, GAD67, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform, GAD65.

J Kanaani1, D Lissin, S F Kash, S Baekkeskov.   

Abstract

GAD67, the larger isoform of the gamma-aminobutyric acid-synthesizing enzyme glutamic acid decarboxylase, is a hydrophilic soluble molecule, postulated to localize at nerve terminals and membrane compartments by heterodimerization with the smaller membrane-anchored isoform GAD65. We here show that the dimerization region in GAD65 is distinct from the NH(2)-terminal membrane-anchoring region and that a membrane anchoring GAD65 subunit can indeed target a soluble subunit to membrane compartments by dimerization. However, only a fraction of membrane-bound GAD67 is engaged in a heterodimer with GAD65 in rat brain. Furthermore, in GAD65-/- mouse brain, GAD67, which no longer partitions into the Triton X-114 detergent phase, still anchors to membranes at similar levels as in wild-type mice. Similarly, in primary cultures of neurons derived from GAD65-/- mice, GAD67 is targeted to nerve terminals, where it co-localizes with the synaptic vesicle marker SV2. Thus, axonal targeting and membrane anchoring is an intrinsic property of GAD67 and does not require GAD65. The results suggest that three distinct moieties of glutamate decarboxylase localize to membrane compartments, an amphiphilic GAD65 homodimer, an amphiphilic GAD65/67 heterodimer, tethered to membranes via the GAD65 subunit, and a hydrophilic GAD67 homodimer, which associates with membranes by a distinct mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10601283     DOI: 10.1074/jbc.274.52.37200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  GABA(A) receptor and glycine receptor activation by paracrine/autocrine release of endogenous agonists: more than a simple communication pathway.

Authors:  Herve Le-Corronc; Jean-Michel Rigo; Pascal Branchereau; Pascal Legendre
Journal:  Mol Neurobiol       Date:  2011-05-06       Impact factor: 5.590

2.  Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.

Authors:  G Sh Burbaeva; I S Boksha; E B Tereshkina; O K Savushkina; T A Prokhorova; E A Vorobyeva
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

3.  Glutamate decarboxylase: loss of N-terminal segment does not affect homodimerization and determination of the oxidation state of cysteine residues.

Authors:  Gino Battaglioli; Hongcheng Liu; Charles R Hauer; David L Martin
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

4.  Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease.

Authors:  Daniel B Rush; Rebecca T Leon; Mark H McCollum; Ryan W Treu; Jianning Wei
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

5.  Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.

Authors:  T A M A Al-Bukhari; P M Radford; G Bouras; C Davenport; S M Trigwell; G-F Bottazzo; M Lai; H L Schwartz; P J Tighe; I Todd
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

6.  Two distinct mechanisms target GAD67 to vesicular pathways and presynaptic clusters.

Authors:  Jamil Kanaani; Julia Kolibachuk; Hugo Martinez; Steinunn Baekkeskov
Journal:  J Cell Biol       Date:  2010-08-30       Impact factor: 10.539

7.  Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles.

Authors:  Hong Jin; Heng Wu; Gregory Osterhaus; Jianning Wei; Kathleen Davis; Di Sha; Eric Floor; Che-Chang Hsu; Richard D Kopke; Jang-Yen Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-12       Impact factor: 11.205

Review 8.  Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Authors:  Sofie Robert; Hannelie Korf; Conny Gysemans; Chantal Mathieu
Journal:  Islets       Date:  2013-03-01       Impact factor: 2.694

Review 9.  Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy.

Authors:  Kerry Thompson
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

10.  Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory.

Authors:  Jorge R Bergado-Acosta; Susan Sangha; Rajeevan T Narayanan; Kunihiko Obata; Hans-Christian Pape; Oliver Stork
Journal:  Learn Mem       Date:  2008-03-05       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.